1 Min Read
* Says its Zhengzhou unit has transferred Hubei-based pharma company to a Shenzhen investment company, for 238 million yuan
Source text in Chinese: goo.gl/CYMnx1
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.